← Study Library
Review · 2016
Anecdotalcounts toward this tierProduct Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee
Altman RD, Bedi A, Karlsson J, et al. · The American Journal of Sports Medicine
Anecdotalcounts toward this tier
Argues higher-molecular-weight and cross-linked HA products show larger treatment effects than low-MW products — the main citation behind molecular-weight marketing claims.
- Population
- Systematic assessment of HA products by molecular weight in knee OA trials
- Intervention
- High-molecular-weight (>=3000 kDa) HA products
- Comparator
- Low-molecular-weight HA products
- Limitations
- Author industry relationships with HA manufacturers; subgroup-level inference; the large 2022 BMJ meta-analysis found no clinically relevant benefit regardless of product.
Cited by
1 entry references this study
- Hyaluronic acid (viscosupplementation)NOT SUPP.
Injections → Conventional